AliMed, Inc.

DUBLIN--( BUSINESS WIRE )--The "Medical Gloves - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. Global Medical Gloves Market to Reach $46.9 Billion by 2030 The global market for Medical Gloves estimated at US$21.8 Billion in the year 2022, is projected to reach a revised size of US$46.9 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2022-2030. Examination Gloves, one of the segments analyzed in the report, is projected to record 10.2% CAGR and reach US$39.8 Billion by the end of the analysis period. Growth in the Surgical Gloves segment is estimated at 9.1% CAGR for the next 8-year period. The COVID-19 pandemic had a profound impact on the production and sales of medical gloves. The increased need for personal protective equipment, including gloves, led to a surge in demand. However, this increased usage also raised concerns about skin damage due to excessive glove usage and environmental issues related to the disposal of medical waste. The pandemic also resulted in a spike in the prices of medical gloves, with average selling prices (ASP) experiencing significant growth from the second quarter of 2020 to the first quarter of 2021. In the competitive landscape of medical gloves, key competitors vie for market share, and their competitive market presence varies from strong to niche or trivial. The global market outlook for medical gloves indicates a wider acceptance of disposable medical gloves, with surgical gloves also experiencing healthy gains. Powder-free gloves have gained popularity due to safety concerns. Hospitals and clinics remain primary end-users of disposable medical gloves. Medical gloves come in various types, including latex and non-latex gloves, with different benefits and drawbacks associated with each. The market includes examination gloves, surgical gloves, and both powdered and powder-free gloves. In the competitive landscape of medical gloves, various world brands play a significant role in the industry's development and innovation. Recent market activity indicates the dynamic nature of this market segment. The U.S. Market is Estimated at $6.9 Billion, While China is Forecast to Grow at 11.7% CAGR Geographically, developed regions continue to be major revenue contributors, while developing regions are evolving into the fastest-growing markets. Malaysia leads global glove production, with top manufacturers like Top Glove, Hartalega, Kossan, and Supermax contributing significantly to the industry. The Medical Gloves market in the U.S. is estimated at US$6.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$10.1 Billion by the year 2030 trailing a CAGR of 11.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.6% and 9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.1% CAGR. What`s New? Special discussions on the global economic climate and market sentiment Coverage on global competitiveness and key competitor percentage market shares Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to digital archives and trademarked research platform Complimentary updates for one year Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes Key Attributes: Report Attribute Details No. of Pages 730 Forecast Period 2022 - 2030 Estimated Market Value (USD) in 2022 $21.8 Billion Forecasted Market Value (USD) by 2030 $46.9 Billion Compound Annual Growth Rate 10.0% Regions Covered Global MARKET TRENDS & DRIVERS An Insight into Global Rubber Gloves Market Innovations Drive Growth Select Innovations Focus on Hygiene & Safety Amidst the Pandemic to Fuel Demand for Disposable Medical Gloves Surging Demand for Disposable Gloves Amidst the COVID-19 Pandemic Significance of Hand Protection in Hospitals and Laboratories Drives Demand for Medical Gloves Rising Number of Medical Professionals and Surgeries Drive Growth in Market Rising Incidence of Hospital Acquired Infections Propels Market Growth Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost from Leading Infections Rising Cases of Chronic Wounds Propel Need for Medical Gloves Global Prevalence of Chronic Wounds by Wound Type Growth in Number of Surgical Procedures to Propel Demand Growth in the Number of Surgeries in the US (2010-2025) and 2001-2010 (in %) Medical Gloves Demand Benefits from the Rise in Number of Cosmetic & Plastic Surgeries Aesthetic Surgical Procedures Worldwide: Percentage Breakdown of Procedures by Type of Surgery for 2020 Increasing Patient Population & Medical Tourism Propel the Market Growing Needs of Aging Population Spur Demand for Medical Gloves Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030 Improving Healthcare Expenditure Turbo Charges Demand World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023 Rise in Number of Diagnostic Laboratories Spurs Demand for Medical Gloves Trend towards Powderless Examination Gloves for Medical Use Latex Gloves Rapidly Lose Share to Synthetic Gloves Nitrile Gloves: An Effective Synthetic Alternative to Natural Rubber Latex Gloves Nitrile Gloves Market Witnesses Exponential Demand amid COVID-19 Crisis Nitrile Gloves Witness Surging Demand Medical Nitrile Gloves Market Endows Stellar Opportunities for Growth Vinyl Disposable Gloves Laced with Inherent Drawbacks Manufacturers of NR Latex Gloves Rise to the Challenge Underplayed Advantages of NRL: Hoping to Reinstate Consumer Confidence Surgical Gloves: Shaped by Comfort, Fit & Barrier Protection COVID-19-Induced Shortages of Surgical Gloves despite Capacity Expansions Surgical Gloves Market Posts Healthy Growth as Demand Continues Skewing Upside Pent-Up Elective Surgery Demand Bodes Well for Surgical Gloves Cumulative Surgery Cancellations Worldwide (In Million) Exploding Demand & Price Spree Enjoyed by Surgical Gloves to Subside Gradually Sustainability as Prominent Buzzword in Surgical Gloves Space New Surgical Gloves to Mitigate Risk of Allergic Contact Dermatitis Popularity of Ambulatory Surgical Centers Surges Demand for Surgical Gloves Implementation of Double Gloving Practice Spurs Growth Opportunities Amidst Concerns over Environmental Pollution, Environmentally Friendly Gloves Find Favor Future of Powdered Gloves Precariously Hangs in Balance Product Variables for Commercial Success Managed Care Vs. Cost Concerns Industry Upbeat on the Technology & Innovation Front Hartalega Develops Non-Leaching Antimicrobial Gloves with Active Ingredient Technology/Product Breakthroughs in Recent Years Demand and Supply Dynamics Durability of Medical Gloves: A Key Issue FOCUS ON SELECT PLAYERS (Total 229 Featured) AliMed, Inc. Abena A/S Angiplast Pvt., Ltd. Adenna, Inc. Adex Medical, Inc. Alliance Rubber Products Sdn. Bhd. American Healthcare Products, Inc. 365 Healthcare Akzenta International SA AlboLand Srl Amax Health Inc. Alsace Protection Amkay Products Pvt. Ltd. Amazing Rubber Products Pvt. Ltd. Amigo Surgi-care Pvt. Ltd. For more information about this report visit https://www.researchandmarkets.com/r/wejr2a About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CHICAGO, Aug. 3, 2023 /PRNewswire/ -- In the near future, the medical radiation shielding industry is poised for significant advancements driven by cutting-edge technologies and increased demand for radiation-based medical procedures. Innovations in materials science and engineering will lead to the development of more efficient and lightweight shielding solutions, enhancing both patient safety and healthcare professionals' protection. With the rise of personalized medicine and targeted therapies, medical facilities will adopt advanced radiation therapies, such as proton therapy and brachytherapy, necessitating the integration of sophisticated shielding systems. Furthermore, the industry's growth will be fueled by a heightened focus on sustainability, with the adoption of eco-friendly and recyclable shielding materials becoming a norm. Collaborations between medical professionals, researchers, and industry experts will accelerate the pace of progress, paving the way for safer, more precise, and environmentally conscious medical radiation shielding practices in the years to come. Medical Radiation Shielding Market in terms of revenue was estimated to be worth $1.4 billion in 2023 and is poised to reach $1.8 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in the Medical Radiation Shielding market is mainly driven by the Increasing usage of radiation therapy for diagnosis, and the rising number of trained radiologic technologists is expected to offer growth opportunities for players operating in the Medical Radiation Shielding market during the forecast period. However, the Lack of adequate healthcare infrastructure and the dearth of skilled oncologists/radiologists are restricting the growth of this market. Download an Illustrative overview: Browse in-depth TOC on "Medical Radiation Shielding Market" 142 - Tables 29 - Figures 200 - Pages Medical Radiation Shielding Market Scope: MRI Shielding Products segment is expected to account for the largest share in 2022. The Medical Radiation Shielding market, by product, has been segmented into MRI Shielding Products, Lead Lined Glass, Doors & Windows, Lead Lined Drywalls & Plywood, Shields, Barriers, Booths, Lead Sheets, Lead Bricks, High-Density Concrete Blocks, X-ray Rooms, Lead Curtains & Screens and Lead Acrylic. Rising healthcare expenditure across developing countries, Increasing investments for cancer research with technological advancements in radiation detection to meet the growing demand. The Diagnostic Shielding segment held the largest market share in the solution market. By solution, the global Medical Radiation Shieldingmarket is broadly segmented into Diagnostic Shielding and Radiation Therapy Shielding. Increasing demand for a number of PET/CT scans for diagnostic imaging will drive the growth of the market. According to a 2020 report from the Canadian Agency for Drugs and Technologies in Health (CADTH), there were 378 MRI units in Canada in 2019. The country also had 305 SPECT units, 271 SPECT-PET units, and 57 PET-CT units in 2019. CT is the most common modality, with 549 machines in Canada, up from 484 machines in 2010; MRI is the second most common, with 378 machines in 2020 from 281 machines in 2010. The number of CT scanners in Canada is well below the average—15 per million population, as opposed to 26—among OECD countries. North America dominates the global Medical Radiation Shielding market. Based on the region, the Medical Radiation Shielding market is segmented into North America, Europe, Asia Pacific and Rest of the world. The North American market is driven by the growing focus on growing government and private investments to meet the increasing demand for cancer treatment. According to a report published by ACS (in October 2020), cancer patients in the US paid USD 5.6 billion out-of-pocket for cancer treatments, including surgical procedures, radiation treatments, and chemotherapy drugs, in 2018. Approximately USD 183 billion was spent in the US on cancer-related healthcare in 2015, and this figure is projected to grow to USD 222.2 billion by 2025 and USD 246 billion by 2030. Request Sample Pages: Medical Radiation Shielding Market Dynamics: Drivers: Increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment Restraints: Lack of adequate healthcare infrastructure Opportunities: Rising healthcare expenditure across developing countries Challenges: High cost of lead in manufacturing radiation accessories Key Market Players: The Key players in the Medical Radiation Shielding market are ESCO Technologies (US), Mirion Technology (US), Nelco Worldwide (US), Gaven Industries Inc. (US), Radiation Protection Products, Inc. (US), Marshield (Canada), Ray-Bar Engineering Corp. (US), Amray Medical (Ireland), A&L Shielding (US), Global Partners in Shielding Inc. (US), Veritas Medical Solutions LLC. (US), AliMed Inc. (US), Protech Medical (US), Ultraray (US), Mars Metal Company (Canada), Nuclear Lead Co. Inc. (US), Nuclear Shields B.V. (Netherlands), Globe Composite Solutions LLC. (US), Shielding International Inc. (US), Bar-Ray Products (US), Xena Shield (India), Burlington Medical (US), SIMAD S.r.l. (Italy) and European EMC Products (UK). Recent Developments: In September 2022, ESCO Technologies partnered with IMRIS, Deerfield Imaging, on a state-of-the-art MRI facility at Boston Children's Hospital located in Boston, Massachusetts. The newly opened Hale Family building will provide diagnostic and treatment capabilities using IMRIS' unique on-demand intraoperative MRI (iMRI) during surgery. In January 2021, Mirion Technologies acquired Sun Nuclear Corporation to strengthen its position in the market. In September 2020, Mirion acquired Biodex Medical Systems, a leader in the medical industry that offers nuclear medicine instruments, medical imaging equipment, and rehabilitation systems. Get 10% Free Customization on this Report: Medical Radiation Shielding Market Advantages: Enhanced Patient Safety: Radiation shielding products, such as lead aprons, thyroid shields, and lead glasses, protect patients from unnecessary exposure to ionizing radiation during medical imaging and radiation-based treatments. This ensures safer procedures with reduced risks of radiation-related health issues. Healthcare Worker Protection: Shielding solutions provide crucial protection to healthcare professionals who work regularly with radiation equipment. Lead-lined barriers and protective apparel shield medical staff from potential long-term health risks associated with radiation exposure, promoting a safer working environment. Regulatory Compliance: Compliance with strict radiation safety regulations is essential for medical facilities. Implementing effective shielding measures ensures adherence to regulatory guidelines, avoiding penalties and legal consequences. Technological Advancements: The market's ongoing advancements in materials science and engineering result in more efficient and innovative shielding solutions. Advancements like composite materials and digital radiography systems offer improved protection without compromising diagnostic image quality. Rising Demand for Medical Imaging and Radiation Therapy: The increasing prevalence of chronic diseases and the aging population drive the demand for medical imaging and radiation therapy. As a result, the need for radiation shielding products and solutions also rises, supporting the growth of the market. Growing Oncology Treatment Segment: Radiation therapy plays a crucial role in cancer treatment. As the number of cancer cases increases globally, the demand for effective radiation shielding products in oncology departments also surges. Evolving Healthcare Infrastructure: The development of new healthcare facilities and the modernization of existing ones lead to an increased adoption of state-of-the-art radiation shielding solutions, improving overall patient care. Sustainability and Eco-friendliness: There is a growing emphasis on sustainable practices in the healthcare industry. Many shielding manufacturers are investing in eco-friendly materials and processes, attracting environmentally conscious healthcare facilities. Global Awareness of Radiation Safety: Greater awareness about the risks of radiation exposure has driven medical professionals and patients alike to prioritize safety measures. This trend fuels the demand for innovative and reliable radiation shielding products. R&D Investments: Significant investments in research and development within the medical radiation shielding sector contribute to continuous improvements in product performance, efficiency, and safety. In conclusion, the medical radiation shielding market offers essential advantages in terms of safety, regulatory compliance, and technological advancements, serving a critical role in safeguarding both patients and healthcare professionals while supporting the broader goals of effective medical imaging and radiation therapy. Related Reports: Medical Radiation Detection Market - Global Forecasts to 2027 Radiotherapy Market - Global Forecasts to 2027 Radiation Detection Monitoring Safety Market - Global Forecasts to 2027 North American Radiation Protection Apron Market - Global Forecasts to 2026 Intraoperative Radiation Therapy Market - Global Forecasts to 2025 About MarketsandMarkets™: MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit ™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected] Research Insight: Visit Our Website: Content Source: Logo: SOURCE MarketsandMarkets

DUBLIN, June 2, 2023 /PRNewswire/ -- The "Global Musculoskeletal Partnering 2016-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. This report provides the full collection of musculoskeletal disease deals signed between the world's pharmaceutical and biotechnology companies since 2016. Trends in musculoskeletal partnering deals Financial deal terms for headline, upfront and royalty by stage of development Musculoskeletal partnering agreement structure Musculoskeletal partnering contract documents Top musculoskeletal deals by value Most active musculoskeletal dealmakers Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report takes readers through the comprehensive musculoskeletal disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering musculoskeletal deals. The report presents financial deal terms values for musculoskeletal deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals. Report scope The report is intended to provide the reader with an in-depth understanding and access to musculoskeletal trends and structure of deals entered into by leading companies worldwide. Global Musculoskeletal Partnering 2016 to 2023 includes: Trends in musculoskeletal dealmaking in the biopharma industry since 2016 Access to headline, upfront, milestone and royalty data Access to hundreds of musculoskeletal deal contract documents Comprehensive access to over 600 musculoskeletal deal records The leading musculoskeletal deals by value since 2016 Most active musculoskeletal dealmakers since 2016 The report includes deals for the following indications: Arthritis, Ankylosing spondylitis, Juvenile arthritis, Osteoarthritis, Psoriatic arthritis, Rheumatoid arthritis, Bone fracture, Hip, Carpel tunnel syndrome, Frozen shoulder, Gout, Knee, Meniscus damage, Muscular dystrophy, Osteoporosis, Paget's disease, Spinal muscular atrophy, Bone pain, Back pain, Muscular pain, Stiffness, Weakness, plus other musculoskeletal indications. In Global Musculoskeletal Partnering 2016 to 2023, available deals and contracts are listed by: Headline value Upfront payment value Royalty rate value Stage of development at signing Deal component type Technology type Specific therapy indication Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The Global Musculoskeletal Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 600 musculoskeletal deals. Analyzing actual contract agreements allows assessment of the following: What are the precise rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How are the sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Key Topics Covered: Chapter 1 - Introduction Chapter 2 - Trends in musculoskeletal dealmaking 2.1. Introduction 2.2. Musculoskeletal partnering over the years 2.3. Musculoskeletal partnering by deal type 2.4. Musculoskeletal partnering by industry sector 2.5. Musculoskeletal partnering by stage of development 2.6. Musculoskeletal partnering by technology type 2.7. Musculoskeletal partnering by therapeutic indication Chapter 3 -Financial deal terms for musculoskeletal partnering 3.1. Introduction 3.2. Disclosed financials terms for musculoskeletal partnering 3.3. Musculoskeletal partnering headline values 3.4. Musculoskeletal deal upfront payments 3.5. Musculoskeletal deal milestone payments 3.6. Musculoskeletal royalty rates Chapter 4 - Leading musculoskeletal deals and dealmakers 4.1. Introduction 4.2. Most active in musculoskeletal partnering 4.3. List of most active dealmakers in musculoskeletal 4.4. Top musculoskeletal deals by value Chapter 5 - Musculoskeletal contract document directory 5.1. Introduction 5.2. Musculoskeletal partnering deals where contract document available Chapter 6 - Musculoskeletal dealmaking by therapeutic target 6.1. Introduction 6.2. Deals by musculoskeletal therapeutic target Companies Mentioned 3D-Side 3SBio A2A Pharmaceuticals Aavis Pharmaceuticals Abarca Abbvie AbCellera AC Bioscience Accenture Actigraph Activbody Active Implants Adaptive Health Additive Orthopaedics Advanced Human Imaging AdventHealth Affinia Therapeutics AGC Asahi Glass AgNovos Healthcare AgomAb Therapeutics Akashi Therapeutics AKL Research and Development AlfaMed Aligos Therapeutics AliMed Alkem Laboratories Allergan AlloSource Almirall Alpine Immune Sciences Altamira Bio Altasciences Alvogen Alvotech Ambry Genetics Amedica Amend Surgical American Association of Neuromuscular & Electrodiagnostic Medicine Amgen Amneal Pharmaceuticals AMRA AMRA Medical Anagenesis Biotechnologies Analysis Group AnaMar Angelini Pharma Angers University Anika Therapeutics ANI Pharmaceuticals Antares Pharma Antibe Therapeutics Apexigen Apple Apsen Farmacutica Aptahem Aptorum Group Aralez Pharmaceuticals Aratana Therapeutics Aravive Biologics argenx ARK Crystal Arrowhead Pharmaceuticals Arthrex Arthrosi Therapeutics Artialis Asahi Kasei Ascendis Pharma AskAt Asklepios Biopharmaceutical Assertio Therapeutics Astellas Pharma AstraZeneca Athrotech Atnahs Pharma Audentes Therapeutics Aurinia Pharmaceuticals Australian Research Council Autotelic BIO Avalere Health Avanos Medical Aveta Biomics AveXis Avidity Biosciences Avion Pharmaceuticals AWB Schraubtechnik und Industriebedarf Axovant Gene Therapies Azellon Cell Therapeutics Aziyo Biologics Back-A-Line Bacterin International Baebies Bamboo Therapeutics Bauerfeind Baxalta Bayer Baylor College of Medicine Bazis NN BC Platforms Beijing Tide Pharmaceutical Benitec Biopharma Berg BGI BillionToOne Bio-Thera Solutions BioAge Labs BioCanRx Biocomposites Biogen BioGen Medical Biohaven Pharmaceuticals BioInvent BioMarin Pharmaceutical BioMed X Innovation Center BionX Medical Technologies BioPharma Forest Bioqube Ventures Bioservo Technologies Biosolution Biosplice Bioventus BioVinc Bison & Rose Blue Belt Technologies Blueprint Medicines Bodycad Boehringer Ingelheim Bone Biologics Bone Therapeutics Brickell Biotech Brigham and Women's Hospital Bristol-Myers Squibb BRM Extremities BSN Medical Burke Therapeutics c-LEcta California Institute for Biomedical Research California Institute for Regenerative Medicine Calimmune Calliditas Therapeutics Camargo Pharmaceutical Services Camber Spine Technologies Can-Fite BioPharma CANbridge Pharmaceuticals Cantargia Capricor Therapeutics Capsigen CareFirst BlueCross BlueShield Carlsmed Carna BioSciences CartiHeal Cartiva CAS Casper Pharma Catabasis Pharmaceuticals Catalyst Pharmaceuticals cbdMD Cedars-Sinai Medical Center Celgene Celltech Cellthera Pharma Cell Therapy Catapult Celltrion Cellular Biomedicine Cel Sci Centinel Spine Centogene Cerhum For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo: SOURCE Research and Markets